Jacci Bainbridge, PharmD, FCCP

 

Jacci Bainbridge, PharmD, FCCP
Professor, Dept of Clinical Pharmacy
University of Colorado Skaggs School of Pharmacy

 


Presentation: Hashing it Out: An Update on the Legalization of Marijuana


Jacquelyn L. Bainbridge, BSPharm, PharmD., FCCP, MSCS, received her doctorate of pharmacy from the University of Colorado where she subsequently completed a specialty residency in neurology. Dr. Bainbridge serves as a clinical pharmacy specialist at the Anschutz Outpatient Pavilion in the Neurology Clinic. This is part of the Neurology Residency Teaching Program at the University of Colorado Denver. Services provided in these clinics include: review of patient information identifying and resolving drug-related problems and consultations; recommending alternative medication therapies for patients; evaluating patients for medication toxicity; providing cost-effective recommendations; providing education to health care practitioners, patients and families; monitoring for drug interactions; avoidance of drug interactions; and reporting of drug interactions. Dr. Bainbridge manages patients with neurologic disease states to include: Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Migraine, Willis-Ekbom Disease formally known as Restless Legs Syndrome. Clinical research is a significant portion of Dr. Bainbridge’s interest. Epilepsy, Multiple Sclerosis, and several neuroprotection trials in Parkinson’s Disease, funded by the NIH, are current research projects she is involved with.

Professional activities. She is the past president of the board of directors for Restless Legs Syndrome Foundation, and member of the Epilepsy Foundation of Colorado professional advisory board, and Epilepsy Foundation of America.   Dr. Bainbridge has been elected as a Fellow of the American College of Clinical Pharmacy (FCCP) and won several student preceptor and teaching awards. Dr. Bainbridge is now a certified Multiple Sclerosis Certified Specialist (MSCS).


Disclosure: Dr. Bainbridge has disclosed she receives grant and/or research support from GW Pharmaceuticals.

Review of Conflicts Policy:  The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming.  For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director.  If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.